ArticleVaccines2021

Receptor-Binding Domain Proteins of SARS-CoV-2 Variants Elicited Robust Antibody Responses Cross-Reacting with Wild-Type and Mutant Viruses in Mice.

Juan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.